Patients' Expectations about Effects of Chemotherapy for Advanced Cancer

被引:876
作者
Weeks, Jane C. [1 ]
Catalano, Paul J. [2 ]
Cronin, Angel [1 ]
Finkelman, Matthew D. [4 ]
Mack, Jennifer W. [3 ]
Keating, Nancy L. [5 ,6 ]
Schrag, Deborah [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA
[4] Tufts Univ, Sch Dent Med, Dept Publ Hlth & Community Serv, Boston, MA 02111 USA
[5] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[6] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
CELL LUNG-CANCER; ADVANCED COLORECTAL-CANCER; CARE OUTCOMES RESEARCH; QUALITY-OF-LIFE; SURVEILLANCE CONSORTIUM; MULTIPLE IMPUTATION; RANDOMIZED-TRIAL; PALLIATIVE CARE; SUPPORTIVE CARE; TREATMENT GOALS;
D O I
10.1056/NEJMoa1204410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. Methods We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. Results Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. Conclusions Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.)
引用
收藏
页码:1616 / 1625
页数:10
相关论文
共 41 条
[1]  
[Anonymous], 2004, J PALLIAT MED, V7, P637
[2]   Patients' Experiences With Care for Lung Cancer and Colorectal Cancer: Findings From the Cancer Care Outcomes Research and Surveillance Consortium [J].
Ayanian, John Z. ;
Zaslavsky, Alan M. ;
Arora, Neeraj K. ;
Kahn, Katherine L. ;
Malin, Jennifer L. ;
Ganz, Patricia A. ;
van Ryn, Michelle ;
Hornbrook, Mark C. ;
Kiefe, Catarina I. ;
He, Yulei ;
Urmie, Julie M. ;
Weeks, Jane C. ;
Harrington, David P. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4154-4161
[3]   Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium [J].
Ayanian, JZ ;
Chrischilles, EA ;
Wallace, RB ;
Fletcher, RH ;
Fouad, MN ;
Kiefe, CI ;
Harrington, DP ;
Weeks, JC ;
Kahn, KL ;
Malin, JL ;
Lipscomb, J ;
Potosky, AL ;
Provenzale, DT ;
Sandler, RS ;
van Ryn, M ;
West, DW .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :2992-2996
[4]   Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group [J].
Burdett, S. ;
Stephens, R. ;
Stewart, L. ;
Tierney, J. ;
Auperin, A. ;
Le Chevalier, T. ;
Le Pechoux, C. ;
Pignon, J. P. ;
Arriagada, R. ;
Higgins, J. ;
Johnson, D. ;
van Meerbeeck, J. ;
Parmar, M. ;
Souhami, R. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) :4617-4625
[5]   Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process [J].
Burns, Catherine M. ;
Broom, Dorothy H. ;
Smith, Wayne T. ;
Dear, Keith ;
Craft, Paul S. .
SUPPORTIVE CARE IN CANCER, 2007, 15 (02) :187-196
[6]  
Catalano P, 2012, MED CARE APPL M 0307
[7]   A Randomized Trial of Two Methods to Disclose Prognosis to Surrogate Decision Makers in Intensive Care Units [J].
Char, Susan J. Lee ;
Evans, Leah R. ;
Malvar, Grace L. ;
White, Douglas B. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (07) :905-909
[8]   Impact of Physician-Patient Discussions on Patient Satisfaction [J].
Chen, Judy Y. ;
Tao, May L. ;
Tisnado, Diana ;
Malin, Jennifer ;
Ko, Clifford ;
Timmer, Martha ;
Adams, John L. ;
Ganz, Patricia A. ;
Kahn, Katherine L. .
MEDICAL CARE, 2008, 46 (11) :1157-1162
[9]  
Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255
[10]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947